Feb 4, 2020
American Catalent takes over MaSTherCell for $ 315 million
American Catalent takes over MaSTherCell for $ 315 million
[ad_1]
February 03, 2020 Today at 1:37 p.m.
MaSTherCell, the service company specializing in cell therapies which is experiencing very significant development in Gosselies, changes shareholder.
MaSTherCell, Gosseliess biotech specializing in the development and production of cellular material, has joined the American Catalent Pharma. Cost…
View On WordPress